IGF2BP3 and cervical cancer: We studied the mechanism of ATL III in cervical cancer cells, and according to the qRT–PCR results, ATL III downregulates IGF2BP3 in HeLa and SiHa cells, which indicates that IGF2BP3 may be a common target of ATL III in HeLa and SiHa cells.